BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+12.76%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$13.3B
AUM Growth
+$13.3B
Cap. Flow
+$1.04B
Cap. Flow %
7.8%
Top 10 Hldgs %
83.56%
Holding
125
New
10
Increased
16
Reduced
22
Closed
5

Top Buys

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$942M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$155M
3
SGEN
Seagen Inc. Common Stock
SGEN
$97.6M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
$52.1M
5
TCDA
Tricida, Inc. Common Stock
TCDA
$47.8M

Top Sells

1
AVXS
AveXis, Inc. Common Stock
AVXS
$144M
2
ABLX
Ablynx NV American Depositary Shares
ABLX
$119M
3
NKTR icon
Nektar Therapeutics
NKTR
$29.3M
4
EXEL icon
Exelixis
EXEL
$14M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
$10.7M

Sector Composition

1 Healthcare 92.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TCDA
26
DELISTED
Tricida, Inc. Common Stock
TCDA
$47.8M 0.36%
+1,600,000
New +$47.8M
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$44.9M 0.34%
321,800
+100,000
+45% +$14M
ABEO icon
28
Abeona Therapeutics
ABEO
$356M
$35M 0.26%
87,375
– –
PHXM
29
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$34.5M 0.26%
308,597
-410
-0.1% -$45.8K
XNCR icon
30
Xencor
XNCR
$594M
$32.3M 0.24%
872,072
– –
ECYT
31
DELISTED
Endocyte, Inc. Common Stock
ECYT
$31.4M 0.24%
2,277,799
– –
BLUE
32
DELISTED
bluebird bio
BLUE
$31.4M 0.24%
15,440
– –
BLCM
33
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$30.2M 0.23%
409,345
-5,813
-1% -$429K
NGNE icon
34
Neurogene
NGNE
$284M
$29M 0.22%
546,708
– –
MRUS icon
35
Merus
MRUS
$5.04B
$26.4M 0.2%
1,160,014
– –
GLPG icon
36
Galapagos
GLPG
$2.06B
$24M 0.18%
259,894
– –
QURE icon
37
uniQure
QURE
$954M
$22.9M 0.17%
605,000
+105,000
+21% +$3.97M
HALO icon
38
Halozyme
HALO
$8.75B
$21.7M 0.16%
1,283,929
-297,495
-19% -$5.02M
MYOK
39
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$21.5M 0.16%
433,121
+142,857
+49% +$7.09M
SLDB icon
40
Solid Biosciences
SLDB
$448M
$20.9M 0.16%
39,192
– –
ZYME icon
41
Zymeworks
ZYME
$1.07B
$19.4M 0.15%
+1,311,085
New +$19.4M
SGMO icon
42
Sangamo Therapeutics
SGMO
$161M
$18.2M 0.14%
1,283,923
-323,656
-20% -$4.6M
AIMT
43
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$18.1M 0.14%
673,908
– –
INSM icon
44
Insmed
INSM
$30.3B
$16.6M 0.12%
700,000
– –
CFRX
45
DELISTED
ContraFect Corporation
CFRX
$15.8M 0.12%
8,941
– –
CMTA
46
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$15.7M 0.12%
1,192,595
+942,595
+377% +$12.4M
BOLD
47
DELISTED
Audentes Therapeutics, Inc
BOLD
$15M 0.11%
393,222
– –
NTLA icon
48
Intellia Therapeutics
NTLA
$1.26B
$15M 0.11%
546,922
-286,873
-34% -$7.85M
SYRE icon
49
Spyre Therapeutics
SYRE
$1.02B
$14.7M 0.11%
55,515
+10,000
+22% +$2.65M
CPRX icon
50
Catalyst Pharmaceutical
CPRX
$2.42B
$11.3M 0.08%
3,621,962
-759,110
-17% -$2.37M
1
2
3 4 5